Rockwell Medical (RMTI) Non-Current Deffered Revenue (2016 - 2024)

Rockwell Medical has reported Non-Current Deffered Revenue for 9 years, with the latest figure at $429000.0 in Q4 2024.

• For the quarter ending Q4 2024, Non-Current Deffered Revenue fell 9.68% year-over-year to $429000.0; the trailing twelve-month figure through Dec 2024 stood at $429000.0 (down 9.68% YoY), and the FY2024 full-year result was $429000.0, down 9.68% from the prior year.
• Non-Current Deffered Revenue for Q4 2024 stood at $429000.0, down from $441000.0 in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $9.5 million in Q1 2020, with the low at $429000.0 in Q4 2024.
• Historically, Non-Current Deffered Revenue has averaged $4.4 million across 5 years, with a median of $4.8 million in 2022.
• Annual changes were most pronounced in 2023 — Non-Current Deffered Revenue plunged 89.33% — and 2024, when it fell 9.45%.
• Rockwell Medical's Non-Current Deffered Revenue stood at $8.0 million in 2020, then retreated by 25.32% to $6.0 million in 2021, then sank by 56.57% to $2.6 million in 2022, then plunged by 81.73% to $475000.0 in 2023, then fell by 9.68% to $429000.0 in 2024.
• The last three Non-Current Deffered Revenue figures came in at $429000.0 (Q4 2024), $441000.0 (Q3 2024), and $452000.0 (Q2 2024), per Business Quant data.